PHOENIX Satellite Event – now online!
PHOENIX: A new player bridging nano-pharmaceutical innovation from design to clinic
A satellite event of ECCPM
Friday, 13 September 2024, 10:00 am – 12:00 pm
Online
PHOENIX supports its customers to overcome difficulties bridging the “innovation valley of death”, enabling transfer of nanopharmaceuticals from lab bench to clinical trials. As an Open Innovation Test Bed (OITB), PHOENIX provides a Single Entry Point (SEP) for a network of facilities, technologies, services and expertise for all the R&D/I and technology transfer aspects from characterization, testing, verification up to scale-up, GMP manufacturing and regulatory guidance in a timely and cost-friendly manner.
Learn about the services of the PHOENIX Open Innovation Test Bed
- Physico-Chemical Characterisation
- In vitro Characterisation
- In vivo Characterisation
- Manufacturing
- Innovation (including regulatory aspects)
Interested in meeting us in person? PHOENIX will also have a booth at the European Consortium for Continuous Pharmaceutical Manufacturing (ECCPM) Forum!
About the ECCPM Forum
To define the contextualization of CM within the global pharmaceutical sector, we have chosen a practical “use cases” approach. These use cases focuses on the investigation, development and implementation of continuous manufacturing strategies – from API synthesis, and downstreaming to the final dosage form.
The knowledge and insights gleaned from these use cases guide thematic focus of the annual ECCPM Forum. The Forum welcomes attendees from diverse pharmaceutical organizations worldwide and features key note lectures on relevant industrial and scientific topics shaping the future of continuous manufacturing in the pharmaceutical industry.
